Latest Funding News

Lefroy Exploration has reported strong, consistent gold assay results from its Lucky Strike deposit, reinforcing confidence in its resource model as it advances towards mining operations targeted for early 2026.

Platinum Capital faces a significant hurdle as L1 Capital, holding nearly 17% of shares, declares opposition to its proposed restructuring scheme. The Board remains supportive but is exploring alternatives.

HITIQ Limited has closed its pro-rata rights issue, raising $360,426 before costs, and is now focusing on placing the remaining shortfall of shares within three months.

Locate Technologies has raised an additional A$239,180 through its At-the-Market facility and expanded its Bitcoin treasury to over 10 BTC, reinforcing its financial strategy amid growth plans.

Infragreen Group Limited has launched a $40 million initial public offering to accelerate growth in sustainable infrastructure across Australia and New Zealand, while strengthening its balance sheet through significant debt repayment.

Greatland Resources Limited is set to list on the ASX following a corporate reorganisation, showcasing robust production at its Telfer gold-copper mine and advancing development at the Havieron project.

Charter Hall has announced a 6% increase in its half-year distribution to 24.38 cents per security for the period ending June 30, 2025, signaling steady growth in its property investment returns.

Mount Burgess Mining has raised $221,806 through a share placement aimed at advancing its Kihabe-Nxuu Project and supporting ongoing operations.

Great Boulder Resources has raised $12.5 million through a placement to institutional investors, positioning the company to fast-track exploration and resource expansion at its flagship Side Well Gold Project.

Provaris Energy has responded to ASX inquiries following a notable surge in its share price and trading volume, denying any undisclosed material information while confirming engagement of a lead manager for a potential capital raising.

Microba Life Sciences Limited has had its trading suspension lifted following a capital raising announcement, signaling renewed market activity for the healthcare company.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.